Showing 1551-1560 of 23120 results for "".
Beyond the Cure: Addressing Psychosocial Needs in Gene Therapy for SCD
https://reachmd.com/programs/project-oncology/psychosocial-needs-gene-therapy-scd/39974/Gene therapy offers transformative potential for individuals with sickle cell disease, but the psychosocial challenges that accompany such a major decision are often underestimated. Hear from Dr. Victoria Coleman-Cowger as she highlights recommendations for supporting emotional wellbeing during andExploring Technological Advances in GI Training: Practical Insights for Clinicians
https://reachmd.com/programs/gi-insights/exploring-technological-advances-in-gi-training-practical-insights-for-clinicians/32875/Artificial intelligence, simulation platforms, augmented reality, and other technological innovations are transforming our approach to GI training. In this expert-led discussion, Dr. Peter Buch sits down with Dr. Nabil Mansour to discuss how we can integrate cutting-edge tools into colonoscopy trainInvestigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study
https://reachmd.com/programs/project-oncology/investigating-at-home-subcutaneous-atezolizumab-for-nsclc-an-ongoing-study/35769/Can the immune checkpoint inhibitor atezolizumab be safely administered subcutaneously at home for patients with non-small cell lung cancer (NSCLC)? That’s the exact question an ongoing study is seeking to answer, and here to discuss the study’s objective, design, and potential implications for homeAdvancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
https://reachmd.com/programs/frontlines-cidp/advancing-cidp-research-targeted-therapies-ai-integration-and-immunological-insights/33069/From innovative diagnostic strategies to targeted immunotherapies, our approach to chronic inflammatory demyelinating polyneuropathy (CIDP) management is rapidly evolving. Dr. Karissa Gable, Assistant Professor of Neurology at Duke University Medical Center, breaks down the new developments that aimAdvancing C3G Care with the Approval of a Complement Factor B Inhibitor
https://reachmd.com/programs/frontlines-c3g/advancing-c3g-care-with-the-approval-of-a-complement-factor-b-inhibitor/35486/Learn about the first treatment approved by the FDA to treat C3 glomerulopathy.Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
https://reachmd.com/programs/neurofrontiers/safety-outcomes-in-ms-clinical-trials-examining-comorbidities-and-adverse-events/32705/Learn how comorbidities are related to adverse events and early discontinuation in phase III multiple sclerosis trials.Exploring Approaches to Management for Bronchiectasis
https://reachmd.com/programs/deep-breaths-updates-chest/exploring-approaches-to-management-for-bronchiectasis/14879/Learn more about the burden of bronchiectasis exacerbations, and how clinicians can manage this condition.The Cardiac Impact of COVID-19: Lessons Learned from the Pandemic
https://reachmd.com/programs/advanced-treatments-innovations-mayo-clinic/the-cardiac-impact-of-covid-19-lessons-learned-from-the-pandemic/12723/What have we learned about the impact of COVID-19 on the heart?ACOG 2021: What Can We Look Forward to?
https://reachmd.com/programs/clinicians-roundtable/acogs-2021-acsm-what-can-we-look-forward-to/12510/Let’s look at some of the clinical updates and advances to be presented at ACOG's 2021 Annual Clinical and Scientific Meeting.Second Ebola Virus Treatment Approved
https://reachmd.com/programs/the-drug-report/second-ebola-virus-treatment-approved/12120/The FDA announced approval for a second ebolavirus treatment nearly seven years after the largest Ebola epidemic in West Africa.